Related Experiment Video
Updated: Aug 16, 2025

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Zinc-finger protein CXXC5 promotes breast carcinogenesis by regulating the TSC1/mTOR signaling pathway
Wenjuan Wang1, Zhaohan Zhang1, Minghui Zhao1
1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Abstract:
CXXC5, a member of the CXXC family of zinc-finger proteins, is associated with numerous pathological processes. However, the pathophysiological function of CXXC5 has not been clearly established. Herein, we found that CXXC5 interacts with the CRL4B and NuRD complexes. Screening of transcriptional targets downstream of the CXXC5-CRL4B-NuRD complex by next-generation sequencing (chromatin immunoprecipitation sequencing) revealed that the complex regulates the transcriptional repression process of a cohort of genes, including TSC1 (tuberous sclerosis complex subunit 1), which play important roles in cell growth and mammalian target of rapamycin signaling pathway regulation, and whose abnormal regulation results in the activation of programmed cell death-ligand protein 1 (PD-L1). Intriguingly, CXXC5 expression increased after stimulation with vitamin B2 but decreased after vitamin D treatment. We also found that the CXXC5-CRL4B-NuRD complex promotes the proliferation of tumor cells in vitro and accelerates the growth of breast cancer in vivo. The expression of CXXC5, CUL4B, and MTA1 increased during the occurrence and development of breast cancer, and correspondingly, TSC1 expression decreased. Meanwhile, a high expression of CXXC5 was positively correlated with the histological grade of high malignancy and poor survival of patients. In conclusion, our study revealed that CXXC5-mediated TSC1 suppression activates the mammalian target of rapamycin pathway, reduces autophagic cell death, induces PD-L1-mediated immune suppression, and results in tumor development, shedding light on the mechanism of the pathophysiological function of CXXC5.
Insights
CXXC5 protein interacts with CRL4B and NuRD complexes, suppressing TSC1 and promoting tumor growth. This CXXC5-mediated pathway activates mTOR signaling, reduces cell death, and induces immune suppression, contributing to cancer development.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- CXXC5, a zinc-finger protein, is implicated in various pathological processes, but its specific pathophysiological role remains unclear.
- Understanding the molecular mechanisms underlying CXXC5 function is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To elucidate the pathophysiological function of CXXC5 and its molecular interactions.
- To investigate the role of the CXXC5-CRL4B-NuRD complex in gene regulation and tumor development, particularly in breast cancer.
Main Methods:
- Chromatin immunoprecipitation sequencing (ChIP-seq) to identify transcriptional targets of the CXXC5-CRL4B-NuRD complex.
- In vitro and in vivo studies to assess the impact of CXXC5 on tumor cell proliferation and breast cancer growth.
- Analysis of gene expression in breast cancer tissues and correlation with clinical parameters.
Main Results:
- CXXC5 interacts with CRL4B and NuRD complexes, regulating transcriptional repression of genes including TSC1.
- The CXXC5-CRL4B-NuRD complex promotes tumor cell proliferation and breast cancer growth by suppressing TSC1, activating mTOR signaling, reducing autophagic cell death, and inducing PD-L1-mediated immune suppression.
- Increased expression of CXXC5, CUL4B, and MTA1, and decreased TSC1 expression correlate with breast cancer progression.
- High CXXC5 expression is linked to higher malignancy grade and poorer patient survival.
Conclusions:
- CXXC5 plays a significant role in tumor development through TSC1 suppression, leading to mTOR pathway activation, reduced autophagy, and immune evasion.
- The CXXC5-CRL4B-NuRD complex represents a potential therapeutic target for breast cancer and other malignancies.
- Further research into CXXC5 regulation by vitamins may offer novel therapeutic strategies.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Canonical Wnt Signaling Pathway
TGF - β Signaling Pathway
Abnormal Proliferation

